These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17489680)

  • 1. Reversing chronic remodeling in heart failure.
    Mudd JO; Kass DA
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):585-98. PubMed ID: 17489680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse ventricular remodeling: mechanical options.
    McGee EC; Gillinov AM; McCarthy PM
    Curr Opin Cardiol; 2006 May; 21(3):215-20. PubMed ID: 16601460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery.
    Burkhoff D; Klotz S; Mancini DM
    J Card Fail; 2006 Apr; 12(3):227-39. PubMed ID: 16624689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
    Milting H; Jacob M; Kassner A; Heimann P; Mannherz HG; Becker G; Meyer HE; Böthig D; Arusoglu L; Morshuis M; Körfer R; El Banayosy A
    J Heart Lung Transplant; 2004 Apr; 23(4):396-404. PubMed ID: 15063398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart.
    Jahanyar J; Youker KA; Loebe M; Assad-Kottner C; Koerner MM; Torre-Amione G; Noon GP
    J Surg Res; 2007 Jun; 140(2):199-203. PubMed ID: 17418861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to attenuate pathological remodeling in heart failure.
    Eapen Z; Rogers JG
    Curr Opin Cardiol; 2009 May; 24(3):223-9. PubMed ID: 19318933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical device-based methods of managing and treating heart failure.
    Mancini D; Burkhoff D
    Circulation; 2005 Jul; 112(3):438-48. PubMed ID: 16027272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac resynchronization therapy: when the pacing site really matters].
    García-Bolao I
    Rev Esp Cardiol; 2007 Feb; 60(2):97-100. PubMed ID: 17338873
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and electrical remodeling as therapeutic targets in heart failure.
    Cutler MJ; Rosenbaum DS; Dunlap ME
    J Electrocardiol; 2007; 40(6 Suppl):S1-7. PubMed ID: 17993305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical treatment of end-stage heart failure.
    Blom AS; Acker MA
    Curr Probl Cardiol; 2007 Oct; 32(10):553-99. PubMed ID: 17920924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.
    Wang J; Tsukashita M; Nishina T; Marui A; Yoshikawa E; Muranaka H; Matsuoka S; Ikeda T
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):465-70. PubMed ID: 19185171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac support devices.
    Rodger M; McRae ME; Jaffer M; Bailey B; Del Signore S
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):169-80. PubMed ID: 20002342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse remodeling during long-term mechanical unloading of the left ventricle.
    Drakos SG; Terrovitis JV; Anastasiou-Nana MI; Nanas JN
    J Mol Cell Cardiol; 2007 Sep; 43(3):231-42. PubMed ID: 17651751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.
    Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R
    J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device-induced molecular changes in the failing myocardium.
    Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
    Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular-assist devices for the treatment of chronic heart failure.
    Drakos SG; Charitos EI; Nanas SN; Nanas JN
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):571-84. PubMed ID: 17489679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of arresting the process of remodeling.
    Somasundaram PE; Chandrashekhar Y
    Med Clin North Am; 2004 Sep; 88(5):1193-207, x. PubMed ID: 15331313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective bridging to recovery after repair: the surgical approach to ventricular reverse remodeling.
    Pitsis AA; Visouli AN; Ninios V; Bougioukas G; Filippatos G; Kremastinos D; Burkhoff D; Long JW
    Artif Organs; 2008 Sep; 32(9):730-5. PubMed ID: 18684205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.